35 pending office actions • 22 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18702300 | Composition for Promoting the Assimilation of an Oligosaccharide | Morinaga Milk Industry Co., Ltd. | HOFFMAN, SUSAN COE | 1655 | Non-Final OA | Apr 17, 2024 |
| 18474513 | METHOD FOR PRODUCING L-AMINO ACID | Ajinomoto Co., Inc. | STAPON, ANTHONY SCOTT | 1656 | Non-Final OA | Sep 26, 2023 |
| 18550853 | Prevention and Treatment of Periodontal and Peri-Implant Disease | Labrida AS | BRANDSEN, BENJAMIN MICHAEL | 1693 | Non-Final OA | Sep 15, 2023 |
| 18281350 | PEPTIDE AND COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT | Kyoto University | HA, JULIE | 1654 | Non-Final OA | Sep 11, 2023 |
| 18354129 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. | SCOTLAND, REBECCA LYNN | 1615 | Non-Final OA | Jul 18, 2023 |
| 18351225 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Evolva SA | MEAH, MOHAMMAD Y | 1652 | Non-Final OA | Jul 12, 2023 |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Danstar Ferment AG | KOROTCHKINA, LIOUBOV G | 1653 | Non-Final OA | Jul 12, 2023 |
| 18334675 | APPLICATION OF LASER-RELEASABLE COMPOSITION | Microcosm Technology Co., Ltd. | GROSSO, GREGORY CHAD | 1748 | Final Rejection | Jun 14, 2023 |
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | Morinaga Milk Industry Co., Ltd. | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Jun 06, 2023 |
| 18250643 | Anti-Microbial Skin-Care Composition Comprising Beta-Glucan and Natural Oil | Lantmännen Oats AB | WEBB, WALTER E | 1612 | Non-Final OA | Apr 26, 2023 |
| 18246797 | Use of Antcin H and Its Derivatives for Treating Central Nervous System Diseases | Alps Biotech Co., Ltd. | LEE, WILLIAM Y | 1623 | Non-Final OA | Mar 27, 2023 |
| 18170671 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | National Yang Ming Chiao Tung University | GRABER, JAMES J | 1631 | Non-Final OA | Feb 17, 2023 |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | Non-Final OA | Jan 17, 2023 |
| 18065167 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | Ajinomoto Co., Inc. | PATEL, VIJAY DINESHBHAI | 1616 | Non-Final OA | Dec 13, 2022 |
| 18009966 | Cognitive Function Improving Agent, Cognitive Function Maintaining Agent, Hippocampus Function Improving Agent, and Hippocampus Function Maintaining Agent | Morinaga Milk Industry Co., Ltd. | DURYEE, ALEXANDER MARSH | 1657 | Non-Final OA | Dec 12, 2022 |
| 17999081 | Use of SAA, rSAA or inhibitors of SAA in the treatment of dysregulated inflammation | Lika Antisepsis Gbr | JUEDES, AMY E | 1644 | Non-Final OA | Nov 17, 2022 |
| 17998559 | DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF | Hunilife Biotechnology, Inc. | HAQ, SHAFIQUL | 1678 | Final Rejection | Nov 11, 2022 |
| 17997041 | USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN CONVERTING ENZYME 2 | Alps Biotech Co., Ltd. | FIEBIG, RUSSELL G | 1655 | Non-Final OA | Oct 25, 2022 |
| 17954709 | Flexible Display Cover Substrate | Microcosm Technology Co., Ltd. | NELSON, MICHAEL B | 1787 | Final Rejection | Sep 28, 2022 |
| 17947596 | L-GLUTAMATE OXIDASE MUTANT | Ajinomoto Co., Inc. | EIX, EMILY FAY | 1653 | Final Rejection | Sep 19, 2022 |
| 17910175 | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity | LANTMÄNNEN FUNCTIONAL FOODS AB | FIEBIG, RUSSELL G | 1655 | Final Rejection | Sep 08, 2022 |
| 17939570 | Liquid Composition for Cleaning, Sanitizing and/or Disinfecting | Corticalis AS | WEBB, WALTER E | 1612 | Final Rejection | Sep 07, 2022 |
| 17799466 | A PROCESS FOR THE PRODUCTION OF A BAKED PRODUCT WITHOUT ADDITION OF SUGAR | Lantmännen Unibake Holding A/S | TRAN, LIEN THUY | 1793 | Final Rejection | Aug 12, 2022 |
| 17713804 | Surfactant and Composition | Ajinomoto Co., Inc. | ISNOR, ALEXANDRA NICOLE | 1611 | Final Rejection | Apr 05, 2022 |
| 17688035 | COMPOSITION, PRODUCTION METHOD FOR PRODUCING THE SAME, AND METHOD OF PREVENTING CAKING | Morinaga Milk Industry Co., Ltd. | CURRENS, GRANT CARSON | 1651 | Final Rejection | Mar 07, 2022 |
| 17639649 | A NOVEL POLYMORPH AND USES THEREOF | Procypra Therapeutics, LLC | BRAUN, MADELINE E | 1624 | Non-Final OA | Mar 02, 2022 |
| 17633386 | Composition for Babies and Infants for Improving Memory Ability in Childhood | Morinaga Milk Industry Co., Ltd. | OGUNBIYI, OLUWATOSIN A | 1645 | Non-Final OA | Feb 07, 2022 |
| 17592938 | Methods for Treatment of Addiction-Reward Behaviors | Timothy P. Murphy | MATTHEWS, WILLIAM H | 3774 | Non-Final OA | Feb 04, 2022 |
| 17559470 | AMINO ACID COMPOSITION HAVING CO-AMORPHOUS STRUCTURE | Ajinomoto Co., Inc. | SAWYER, JENNIFER C | 1691 | Final Rejection | Dec 22, 2021 |
| 17611312 | COMPOSITION | Morinaga Milk Industry Co., Ltd. | EDWARDS, JESSICA FAYE | 1657 | Non-Final OA | Nov 15, 2021 |
| 17480792 | METHOD FOR PRODUCING ALLOLACTOSE | Ajinomoto Co., Inc. | MARTIN, RACHEL E | 1657 | Final Rejection | Sep 21, 2021 |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | Non-Final OA | Sep 10, 2021 |
| 17193092 | Consumable Product Comprising Malted Dehulled Oats | LANTMÄNNEN FUNCTIONAL FOODS AB | KIM, BRYAN | 1792 | Non-Final OA | Mar 05, 2021 |
| 17193141 | Consumable Product Comprising Malted Wheat | LANTMÄNNEN FUNCTIONAL FOODS AB | KIM, BRYAN | 1792 | Non-Final OA | Mar 05, 2021 |
| 16985492 | PERIODONTAL DISEASE TREATMENT | Straumann Holding AG | EIDE, HEIDI MARIE | 3772 | Non-Final OA | Aug 05, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial